SENORES Share Price Performance
₹0
-510.75 (-100.00%)
Price ₹0
Share Pricen/a
Senores Pharmaceuticals Limited (NSE:SENORES) Released Earnings Last Week And Analysts Lifted Their Price Target To ₹1,081
Jan 23
Senores Pharmaceuticals Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
SENORES Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Senores Pharmaceuticals Limited Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 30, 2026
- 22.06
- 54.90%
- 18.36%
- 28.9%
About SENORES
- Founded
- 2017
- Employees
- 194
- CEO
- WebsiteView website
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics, as well as management and consultancy services. The company was incorporated in 2017 and is based in Ahmedabad, India.
